Anpario (ANP) Share Price, News & Analysis

Company Overview

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands. The company's hygiene and insect control category contain products, such as water sanitation tablets, 100% natural insect control powders, and natural drying agents that minimizes the environmental microbial burden, supports the gut health, and animal performance under the Credence, Mitex, and Clean & Dry brands; and toxin management category products, such as mycotoxin binders under the Anpro brand. It has operations in the Americas, Asia, Europe, the Middle East, and Africa. The company was formerly known as Kiotech International plc and changed its name to Anpario plc in November 2011. Anpario plc was founded in 1996 and is headquartered in Worksop, the United Kingdom.

Key Stats

• Today's Range: 420 to 440
• 50-Day Range: 325 to 477.50
• 52-Week Range: 241 to 488.55
• Volume: 25,276 shs
• Average Volume: 50,644 shs
• Market Capitalization: £72.79 million
• P/E Ratio: 23.56
• Dividend Yield: 2.58%
• Price Target: GBX 435
• Consensus Rating: Buy

Anpario Stock Analysis - MarketRank™

Anpario scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Buy

Consensus Rating

Anpario has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Anpario has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Anpario is 23.56, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.04.

Price to Earnings Ratio vs. Sector

The P/E ratio of Anpario is 23.56, which means that it is trading at a more expensive P/E ratio than the Consumer Defensive sector average P/E ratio of about 11.24.

Price to Book Value per Share Ratio

Anpario has a P/B Ratio of 2.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for ANP.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Anpario pays a meaningful dividend of 2.36%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Anpario does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Anpario is 60.74%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for ANP.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Anpario this week, compared to 1 article on an average week.

Search Interest

1 people have searched for ANP on MarketBeat in the last 30 days.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Anpario insiders have bought more of their company's stock than they have sold. Specifically, they have bought £15,036.44 in company stock and sold GBX 0 in company stock.

Percentage Held by Insiders

30.51% of the stock of Anpario is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

44.05% of the stock of Anpario is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ANP Stock Analysis - Frequently Asked Questions

How have ANP shares performed this year?

Anpario's stock was trading at GBX 391.50 at the beginning of the year. Since then, ANP stock has increased by 9.0% and is now trading at GBX 426.67.
View the best growth stocks for 2025 here.

How were Anpario's earnings last quarter?

Anpario plc (LON:ANP) announced its quarterly earnings data on Monday, March, 31st. The company reported $28.40 earnings per share for the quarter. Anpario had a trailing twelve-month return on equity of 8.74% and a net margin of 9.23%.

How do I buy shares of Anpario?

Shares of ANP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Anpario own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Anpario investors own include EnQuest (ENQ), Centamin (CEY), Genel Energy (GENL), IQE (IQE), Lloyds Banking Group (LLOY), Oxford Biomedica (OXB) and Tullow Oil (TLW).

Company Calendar

• Last Earnings: 3/31/2025
• Today: 5/06/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Consumer Defensive
• Industry: Packaged Foods
• Sub-Industry: Consumer Goods
• Current Symbol: LON:ANP
• CIK: N/A
• Web: www.anpario.com
• Phone: +44-1909-537380
• Fax: N/A
• Employees: 109
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 435
• High Stock Price Target: GBX 500
• Low Stock Price Target: GBX 370
• Potential Upside/Downside: +2.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX 18.11
• Trailing P/E Ratio: 23.56
• Forward P/E Ratio: 18.10
• P/E Growth: N/A
• Net Income: £3.09 million
• Net Margins: 9.23%
• Pretax Margin: N/A
• Return on Equity: 8.74%
• Return on Assets: 5.51%

Debt

• Debt-to-Equity Ratio: 0.10
• Current Ratio: 6.15
• Quick Ratio: 5.16

Sales & Book Value

• Annual Sales: £33.50 million
• Price / Sales: 2.17
• Cash Flow: GBX 57.39 per share
• Price / Cash Flow: 7.43
• Book Value: GBX 212.74 per share
• Price / Book: 2.01

Miscellaneous

• Outstanding Shares: 17,060,624
• Free Float: N/A
• Market Cap: £72.79 million
• Optionable: Not Optionable
• Beta: 0.58